Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
Clinical trial NCT04175522 · COMPLETED
Trial details
- NCT number
- NCT04175522
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2020-06-11
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.